RARE.Qc Impact Stories

RARE.Qc Impact Stories

Advancing Rare Disease Research: The Importance of Working Together

Written by Sonia Gobeil, Cofounder and Valérie Deraiche, Communications and Program Director at the Ataxia Charlevoix-Saguenay Foundation - How can we advance research...
Read More >

2025 Rare Disease Bike Tour

Written by Ryan Hull, RARE.Qc Student member - A single rare disease affects fewer than 1 in 2,000 people by definition, but together they affect nearly 700,000 Quebecers. Because of how rare their cases are, patients...
Read More >

1 in 12 Canadians. Zero Hours of Training.

Written by Leah Sarah Peer, Peer Medical Foundation | RARE.Qc EDI Committee - Rare diseases affect an estimated 300 million people worldwide and 1 in 12 Canadians (Lancet Global Health, 2024). And yet, in country after country...
Read More >

In Charlevoix, Some Realities Are Invisible. They Are Lived. Rare Diseases Are One of Them.

Written by Céleste Paré, Student Researcher, Marjolaine Tremblay, and Isabelle Lessard, Researchers at the ÉCOBES-Recherche et transfert Centre, Cégep de Jonquière - Photo (Charle)Voix: Shedding Light on Rare Diseases...
Read More >

CAN-ACT Registry: Building Canada’s First National Registry for Heritable Thoracic Aortic Diseases

Written by Maria El Bizri, Knowledge and Community Mobilization Officer, Loeys-Dietz Syndrome Foundation Canada - Rare diseases often face...
Read More >

From Lebanon to Montreal: Discovering the Power of Collaboration in Rare Disease Research

Written by Daniel Charouf ---- As a pediatric neurologist trained in Lebanon, my journey into neurogenetics has been shaped by both challenge and opportunity...
Read More >
Blog-Post

Interested in sharing an impact story?

Highlight your projects, discoveries, initiatives, collaborations, or reflections related to rare diseases. We invite members of the RARE.Qc community to submit a short article written in accessible language to showcase their achievements, lessons learned, and the impact of their activities across the network and the rare disease community.